Interestingly, when investigating the relationship between CBS and patient prognostic, a high CBS expression was associated with a better patient survival in IDHm‐1p/19q co‐deleted gliomas, suggesting that CBS can be used as a novel prognostic biomarker in this specific subgroup of gliomas (Fig 6B). The gene discussed is CBS; the disease is glioma.